Heterogeneity of Human Bone Marrow in Cardiovacular Disease

Heterogeneity of Human Bone Marrow in Cardiovacular Disease - RECALL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00024563

Enrollment

150

Registered

2021-02-18

Start date

2021-02-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I25

Interventions

Group 1: Ischemic Cardiomyopathy with reduced EF (Ejection fraction) Group 2: Coronary heart disease with preserved EF Group 3: No coronary artery disease

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Planned cardiac surgery with sternotomy 2) fits one of the study arms

Exclusion criteria

Exclusion criteria: - active cancer - past radiation or chemotherapy - active infection

Design outcomes

Primary

Measure	Time frame
Hematopoietic stem cells have a heterogeneous gene expression profil	—

Secondary

Measure	Time frame
Peripheral blood monocytes have a heterogeneous gene expression profil	—

Countries

Germany

Contacts

Public ContactTimo Heidt

Universitäts-Herzzentrum Freiburg Bad Krozingen

timo.heidt@universitaets-herzzentrum.de076127037814

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026